Literature DB >> 719119

Application of the four-parameter logistic model to bioassay: comparison with slope ratio and parallel line models.

A Vølund.   

Abstract

Bioassays with a quantitative response showing a sigmoid log-dose relationship can be analysed by fitting a non-linear dose-response model directly to the data. It is demonstrated that the four-parameter logistic model, previously applied to immunoassay (Healy 1972), is applicable to the free fat cell bioassay of insulin (Moody, Stan, Stan and Gliemann 1974). It is shown that the standard slope ratio and parallel line models for bioassay can be considered as approximations to the logistic in the extreme dose regions, while the parallel line model can be expected to fit in the middle region. The full statistical analysis of the four-parameter logistic model applied to a general assay design is described. An APL computer program has been developed to facilitate the calculations, which include non-linear curve-fitting, tests of goodness of fit and parallelity, as well as point and interval estimates of the relative potency. Examples of free fat cell bioassays of insulin that have been analysed according to these methods are given. Efficient estimation of the potency calls for concentrating the doses in the region with the steepest slope of the dose-response curve. With respect to testing the parallelity and to allow for assay-to-assay variability and unpredictable potencies, it may be preferable to use an assay design with doses distributed over a wide range and to apply a dose-response model which, like the four-parameter logistic, is capable of fitting over the whole feasible dose range.

Entities:  

Mesh:

Year:  1978        PMID: 719119

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  19 in total

1.  Additional disulfide bonds in insulin: Prediction, recombinant expression, receptor binding affinity, and stability.

Authors:  Tine N Vinther; Ingrid Pettersson; Kasper Huus; Morten Schlein; Dorte B Steensgaard; Anders Sørensen; Knud J Jensen; Thomas Kjeldsen; František Hubalek
Journal:  Protein Sci       Date:  2015-03-16       Impact factor: 6.725

2.  Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential.

Authors:  Kalpana Tilekar; Neha Upadhyay; Jessica D Hess; Lucasantiago Henze Macias; Piotr Mrowka; Renato J Aguilera; Franz-Josef Meyer-Almes; Cristina V Iancu; Jun-Yong Choe; C S Ramaa
Journal:  Eur J Med Chem       Date:  2020-07-02       Impact factor: 6.514

3.  The advantages of linear concentration-response curves for in vitro bioassays with environmental samples.

Authors:  Beate I Escher; Peta A Neale; Daniel L Villeneuve
Journal:  Environ Toxicol Chem       Date:  2018-07-11       Impact factor: 3.742

4.  Discovery of novel N-substituted thiazolidinediones (TZDs) as HDAC8 inhibitors: in-silico studies, synthesis, and biological evaluation.

Authors:  Neha Upadhyay; Kalpana Tilekar; Niklas Jänsch; Markus Schweipert; Jessica D Hess; Luca Henze Macias; Piotr Mrowka; Renato J Aguilera; Jun-Yong Choe; Franz-Josef Meyer-Almes; C S Ramaa
Journal:  Bioorg Chem       Date:  2020-05-15       Impact factor: 5.275

5.  An EM Algorithm for Fitting a 4-Parameter Logistic Model to Binary Dose-Response Data.

Authors:  Gregg E Dinse
Journal:  J Agric Biol Environ Stat       Date:  2011-06-01       Impact factor: 1.524

6.  Thailandepsins: bacterial products with potent histone deacetylase inhibitory activities and broad-spectrum antiproliferative activities.

Authors:  Cheng Wang; Leonhard M Henkes; Leah B Doughty; Min He; Difei Wang; Franz-Josef Meyer-Almes; Yi-Qiang Cheng
Journal:  J Nat Prod       Date:  2011-07-27       Impact factor: 4.050

7.  Insulin analog with additional disulfide bond has increased stability and preserved activity.

Authors:  Tine N Vinther; Mathias Norrman; Ulla Ribel; Kasper Huus; Morten Schlein; Dorte B Steensgaard; Thomas Å Pedersen; Ingrid Pettersson; Svend Ludvigsen; Thomas Kjeldsen; Knud J Jensen; František Hubálek
Journal:  Protein Sci       Date:  2013-01-17       Impact factor: 6.725

8.  Engineering of insulin receptor isoform-selective insulin analogues.

Authors:  Tine Glendorf; Carsten E Stidsen; Mathias Norrman; Erica Nishimura; Anders R Sørensen; Thomas Kjeldsen
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

9.  Novel covalently linked insulin dimer engineered to investigate the function of insulin dimerization.

Authors:  Tine N Vinther; Mathias Norrman; Holger M Strauss; Kasper Huus; Morten Schlein; Thomas Å Pedersen; Thomas Kjeldsen; Knud J Jensen; František Hubálek
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

10.  Systematic evaluation of the metabolic to mitogenic potency ratio for B10-substituted insulin analogues.

Authors:  Tine Glendorf; Louise Knudsen; Carsten E Stidsen; Bo F Hansen; Anne Charlotte Hegelund; Anders R Sørensen; Erica Nishimura; Thomas Kjeldsen
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.